rs375708869
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBS1_Supporting
The NM_001083961.2(WDR62):c.3589C>A(p.Pro1197Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000465 in 1,614,032 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001083961.2 missense
Scores
Clinical Significance
Conservation
Publications
- microcephaly 2, primary, autosomal recessive, with or without cortical malformationsInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics, Illumina, G2P, ClinGen
- autosomal recessive primary microcephalyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001083961.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| WDR62 | NM_001083961.2 | MANE Select | c.3589C>A | p.Pro1197Thr | missense | Exon 30 of 32 | NP_001077430.1 | ||
| WDR62 | NM_001411145.1 | c.3574C>A | p.Pro1192Thr | missense | Exon 30 of 32 | NP_001398074.1 | |||
| WDR62 | NM_173636.5 | c.3574C>A | p.Pro1192Thr | missense | Exon 30 of 32 | NP_775907.4 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| WDR62 | ENST00000401500.7 | TSL:1 MANE Select | c.3589C>A | p.Pro1197Thr | missense | Exon 30 of 32 | ENSP00000384792.1 | ||
| WDR62 | ENST00000587391.6 | TSL:1 | n.*3449C>A | non_coding_transcript_exon | Exon 28 of 30 | ENSP00000465525.1 | |||
| WDR62 | ENST00000587391.6 | TSL:1 | n.*3449C>A | 3_prime_UTR | Exon 28 of 30 | ENSP00000465525.1 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152160Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000358 AC: 9AN: 251378 AF XY: 0.0000368 show subpopulations
GnomAD4 exome AF: 0.0000246 AC: 36AN: 1461872Hom.: 0 Cov.: 34 AF XY: 0.0000261 AC XY: 19AN XY: 727234 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000256 AC: 39AN: 152160Hom.: 0 Cov.: 33 AF XY: 0.000242 AC XY: 18AN XY: 74330 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
Inborn genetic diseases Uncertain:1
The c.3589C>A (p.P1197T) alteration is located in exon 30 (coding exon 30) of the WDR62 gene. This alteration results from a C to A substitution at nucleotide position 3589, causing the proline (P) at amino acid position 1197 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
WDR62-related disorder Uncertain:1
The WDR62 c.3589C>A variant is predicted to result in the amino acid substitution p.Pro1197Thr. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.060% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/19-36594319-C-A). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.
not provided Uncertain:1
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at